| Pereira LI, Dorta ML, Pereira AJ, et al.
Increase of NK cells and proinflammatory monocytes are associated with the clinical improvement of diffuse cutaneous leishmaniasis after immunochemotherapy with BCG/Leishmania antigens. [Case Reports, Journal Article, Research Support, Non-U.S. Gov't]
Am J Trop Med Hyg 2009 Sep; 81(3):378-83.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Carcelén J, Iniesta V, Fernández-Cotrina J, et al.
The Chimerical Multi-Component Q protein from Leishmania in the absence of adjuvant protects dogs against an experimental Leishmania infantum infection. [JOURNAL ARTICLE]
Vaccine 2009 Aug 7.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Botelho AC, Mayrink W, Oliveira RC
Alterations in phenotypic profiles of peripheral blood cells from patients with human American cutaneous leishmaniasis following treatment with an antimonial drug and a vaccine. [JOURNAL ARTICLE]
Acta Trop 2009 Jul 21.
Abstract | Full Citation | | Selvapandiyan A, Dey R, Nylen S, et al.
Intracellular replication-deficient Leishmania donovani induces long lasting protective immunity against visceral leishmaniasis. [Journal Article]
J Immunol 2009 Aug 1; 183(3):1813-20.
Abstract | Full Citation | Find Related Articles | | Rasouli M, Zavaran Hoseini A, Kazemi B, et al.
Expression of Recombinant Heat-Shock Protein 70 of MCAN/IR/96/LON-49, a Tool for Diagnosis and Future Vaccine Research. [Journal Article]
Iran J Immunol 2009 Jun; 6(2):75-86.
Abstract | Full Citation | Find Related Articles | | Dey A, Kumar U, Sharma P, et al.
Immunogenicity of candidate chimeric DNA vaccine against tuberculosis and leishmaniasis. [JOURNAL ARTICLE]
Vaccine 2009 Jun 23.
Abstract | Full Citation | Find Related Articles | | Peters NC, Kimblin N, Secundino N, et al.
Vector transmission of leishmania abrogates vaccine-induced protective immunity. [Journal Article]
PLoS Pathog 2009 Jun; 5(6):e1000484.
Abstract | Full Citation | | Samant M, Gupta R, Kumari S, et al.
Immunization with the DNA-encoding N-terminal domain of proteophosphoglycan of Leishmania donovani generates Th1-Type immunoprotective response against experimental visceral leishmaniasis. [Journal Article]
J Immunol 2009 Jul 1; 183(1):470-9.
Abstract | Full Citation | Find Related Articles | | Noazin S, Khamesipour A, Moulton LH, et al.
Efficacy of killed whole-parasite vaccines in the prevention of leishmaniasis-A meta-analysis. [JOURNAL ARTICLE]
Vaccine 2009 Jun 17.
Abstract | Full Citation | Find Related Articles | | Ali SA, Rezvan H, McArdle SE, et al.
CTL responses to Leishmania mexicana gp63-cDNA vaccine in a murine model. [Journal Article, Research Support, Non-U.S. Gov't]
Parasite Immunol 2009 Jul; 31(7):373-83.
Abstract | Full Citation |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
